Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
about
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Mycophenolate plus methylpredn ...... ver-masked, multicentre trial.
@en
Mycophenolate plus methylpredn ...... ver-masked, multicentre trial.
@nl
type
label
Mycophenolate plus methylpredn ...... ver-masked, multicentre trial.
@en
Mycophenolate plus methylpredn ...... ver-masked, multicentre trial.
@nl
prefLabel
Mycophenolate plus methylpredn ...... ver-masked, multicentre trial.
@en
Mycophenolate plus methylpredn ...... ver-masked, multicentre trial.
@nl
P2093
P1476
Mycophenolate plus methylpredn ...... rver-masked, multicentre trial
@en
P2093
Anja Eckstein
Claudio Marcocci
Dagmar Führer
Danila Covelli
Elena Kampmann
Elisa Kolbe
European Group on Graves' Orbitopathy (EUGOGO)
Francesca Menconi
George J Kahaly
Irene Campi
P304
P356
10.1016/S2213-8587(18)30020-2
P577
2018-01-31T00:00:00Z